Lucy Elliss-Brookes
Overview
Explore the profile of Lucy Elliss-Brookes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
896
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swann R, Lyratzopoulos G, Rubin G, Elliss-Brookes L, McPhail S
Cancer Epidemiol
. 2024 Aug;
92:102607.
PMID: 39167911
Background: Diagnosis of cancer soon after emergency care use is associated with adverse prognosis. We aimed to more precisely explore different definitions of emergency diagnosis. Methods: For 43,383 patients in...
2.
Liu H, Stiller C, Crooks C, Rous B, Bythell M, Broggio J, et al.
Br J Haematol
. 2022 Sep;
199(5):728-738.
PMID: 36122574
This analysis is the largest population-based study to date to provide contemporary and comprehensive epidemiological estimates of all third edition of the International Classification of Diseases for Oncology (ICD-O-3) coded...
3.
Merriel S, Ball S, Bright C, Mak V, Gildea C, Paley L, et al.
Eur J Cancer Care (Engl)
. 2022 May;
31(5):e13606.
PMID: 35570375
Objective: To assess the impact of the fourth Be Clear on Cancer (BCoC) 'Blood in Pee' (BiP) campaign (July to September 2018) on bladder and kidney cancer symptom awareness and...
4.
Eberhardt J, Bright C, Gildea C, Adeghe O, Mak V, Paley L, et al.
Eur J Cancer Care (Engl)
. 2022 Apr;
31(3):e13583.
PMID: 35384107
Objective: More than a third of women diagnosed with breast cancer in England, and over half of those who die from it, are over 70. The Be Clear on Cancer...
5.
Ingleby F, Woods L, Atherton I, Baker M, Elliss-Brookes L, Belot A
BMC Public Health
. 2022 Jan;
22(1):90.
PMID: 35027042
Background: People living in more deprived areas of high-income countries have lower cancer survival than those in less deprived areas. However, associations between individual-level socio-economic circumstances and cancer survival are...
6.
Sweeting M, Oliver-Williams C, Teece L, Welch C, de Belder M, Coles B, et al.
Int J Epidemiol
. 2022 Jan;
50(6):1768-1779.
PMID: 34999882
No abstract available.
7.
West J, Card T, Bishton M, Lanyon P, Ban L, Bythell M, et al.
J Intern Med
. 2021 Dec;
291(4):493-504.
PMID: 34875131
Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare hyper-inflammatory condition with poor outcomes. Objectives: Few population-based estimates of the incidence and survival in adults exist. We aimed to provide these data...
8.
Falcaro M, Castanon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, et al.
Lancet
. 2021 Nov;
398(10316):2084-2092.
PMID: 34741816
Background: Human papillomavirus (HPV) immunisation with a bivalent vaccine (Cervarix) was introduced in England, UK, in Sept 1, 2008: routine vaccination was offered to girls aged 12-13 years with a...
9.
Ball S, Hyde C, Hamilton W, Bright C, Gildea C, Wong K, et al.
Br J Cancer
. 2021 Oct;
126(2):187-195.
PMID: 34718357
Background: A two-phase 'respiratory symptoms' mass media campaign was conducted in 2016 and 2017 in England raising awareness of cough and worsening shortness of breath as symptoms warranting a general...
10.
Bishton M, Stilwell P, Card T, Lanyon P, Ban L, Elliss-Brookes L, et al.
Br J Haematol
. 2021 Aug;
194(6):1039-1044.
PMID: 34386978
We assessed the validity of coded healthcare data to identify cases of haemophagocytic lymphohistiocytosis (HLH). Hospital Episode Statistics (HES) identified 127 cases within five hospital Trusts 2013-2018 using ICD-10 codes...